Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term elderly-patients. Found 9 abstracts

Wierda WG, Zelenetz AD, Gordon LI, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Byrd JC, Caimi P, Fayad LE, Fisher RI, Glenn MJ, Habermann TM, Harris NL, Hernandez-Ilizaliturri F, Hoppe RT, Horwitz SM, Kaminski MS, Kelsey CR, Kim YH, Krivacic S, LaCasce AS, Martin MG, Nademanee A, Porcu P, Press O, Rabinovitch R, Reddy N, Reid E, Roberts K, Saad AA, Snyder ED, Sokol L, Swinnen LJ, Vose JM, Yahalom J, Dwyer MA, Sundar H. NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2017. J Natl Compr Canc Netw. 2017 Mar;15(3):293-311.
Khrizman P, Niland JC, ter Veer A, Milne D, Dunn KB, Carson WE, Engstrom PF, Shibata S, Skibber JM, Weiser MR, Schrag D, Benson AB. Postoperative Adjuvant Chemotherapy Use in Patients With Stage II/III Rectal Cancer Treated With Neoadjuvant Therapy: A National Comprehensive Cancer Network Analysis. Journal of Clinical Oncology. 2013 Jan;31(1):30-8.
Kumar A, Vanderplas A, LaCasce AS, Rodriguez MA, Crosby AL, Lepisto E, Czuczman MS, Nademanee A, Niland J, Gordon LI, Millenson M, Zelenetz AD, Friedberg JW, Abel GA. Lack of benefit of central nervous system prophylaxis for diffuse large B-cell lymphoma in the rituximab era. Cancer. 2012 Jun;118(11):2944-51.   PMCID: not NIH funded
Crawford J, Allen J, Armitage J, Blayney DW, Cataland SR, Heaney ML, Htoy S, Hudock S, Kloth DD, Kuter DJ, Lyman GH, McMahon B, Steensma DP, Vadhan-Raj S, Westervelt P, Westmoreland M. Myeloid Growth Factors. Journal of the National Comprehensive Cancer Network. 2011 Aug;9(8):914-+.   PMCID: not NIH funded
Van Cleave JH, Egleston BL, Bourbonniere M, McCorkle R. Combining Extant Datasets with Differing Outcome Measures Across Studies of Older Adults after Cancer Surgery. Research in Gerontological Nursing. 2011 Jan;4(1):36-46.   PMCID: PMC3263316
Lazarus HM, Zhang MJ, Carreras J, Hayes-Lattin BM, Ataergin AS, Bitran JD, Bolwell BJ, Freytes CO, Gale RP, Goldstein SC, Hale GA, Inwards DJ, Klumpp TR, Marks DI, Maziarz RT, McCarthy PL, Pavlovsky S, Rizzo JD, Shea TC, Schouten HC, Slavin S, Winter JN, van Besien K, Vose JM, Hari PN. A Comparison of HLA-Identical Sibling Allogeneic versus Autologous Transplantation for Diffuse Large B Cell Lymphoma: A Report from the CIBMTR. Biology of Blood and Marrow Transplantation. 2010 Jan;16(1):35-45.   PMCID: PMC2929576
Engstrom PF, Langer CJ. The Balducci article reviewed. ONCOLOGY-NEW YORK. 2006 Feb;20(2):144-+.
Langer CJ. The Lilenbaum article reviewed. ONCOLOGY-NEW YORK. 2004 Sep;18(10):1330-3.
Langer C, Lilenbaum R. Role of chemotherapy in patients with poor performance status and advanced non-small cell lung cancer. Seminars in Oncology. 2004 Dec 11;31(6):8-15.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term elderly-patients

elderly-patients non-hodgkins-lymphoma cell lung-cancer quality-of-life randomized-trial iii randomized-trial phase-iii paclitaxel aggressive lymphoma cisplatin Oncology bone-marrow-transplantation central nervous system prophylaxis diffuse large B-cell lymphoma-propensity score analysis-health services research 1995 evallier b-v13-p1564 phase-ii trial study-group dshnhl 1st-line treatment patients receiving chemotherapy group medical outcomes single-agent ibrutinib Allogeneic transplantation fever intermediate-grade controlled phase-iii metaanalysis chemotherapy-induced 2002 rischilles e-v9-p203 regimens chemotherapy functional status 1993 horney ca-medical care-v31-p247 vinorelbine 2007 corkle r-urol nurs-v27-p65 enrollment colony-stimulating factor survival breast-cancer age cns prophylaxis 17p deletion 1994 horney ca-medical care-v32-p40 open-label health maintenance organization high-dose chemotherapy initial therapy multicenter supportive care Unrelated gemcitabine plus plus gemcitabine 1989 corkle r-cancer-v64-p1375 care information myeloid growth colorectal-cancer plus chlorambucil chop chemotherapy clinical documentation preoperative chemoradiation health survey sf-36 follow-up 2002 ng s-users manual e unpub 1998 corkle r-users manual symptom previously untreated patients lung-cancer population-based cohort intervention relapse neutropenia chemotherapy plus iii colon-cancer carboplatin NCCN Guidelines intrathecal chemotherapy european fee-for-service risk-factors malignant-lymphoma factors complex karyotype NCCN Clinical Practice Guidelines 1997 ang ch-phys med rehabil sta-v11-p397 induced febrile clinical-trials rituximab 1994 corkle r-research in nursing & health-v17-p243 home care Hodgkin lymphoma reduced-intensity
Last updated on Friday, January 03, 2020